EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

DNA Repair and Therapeutic Strategies in Cancer Stem Cells

Matthew S Gillespie, Ciara M Ward, Clare C Davies iD

Cancers · 22.03.2023 · 15 (6) · 1897

DOI: 10.3390/cancers15061897 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 22.03.2023. Verfasst von Matthew S Gillespie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, University of Birmingham PhD studentship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First-line cancer treatments successfully eradicate the differentiated tumour mass but are comparatively ineffective against cancer stem cells (CSCs), a self-renewing subpopulation thought to be responsible for tumour initiation, metastasis, heterogeneity, and recurrence. CSCs are thus presented as the principal target for elimination during cancer treatment. However, CSCs are challenging to drug target because of numerous intrinsic and extrinsic mechanisms of drug resistance. One such mechanism that remains relatively understudied is the DNA damage response (DDR). CSCs are presumed to possess properties that enable enhanced DNA repair efficiency relative to their highly proliferative bulk progeny, facilitating improved repair of double-strand breaks induced by radiotherapy and most chemotherapeutics. This can occur through multiple mechanisms, including increased expression and splicing fidelity of DNA repair genes, robust activation of cell cycle checkpoints, and elevated homologous recombination-mediated DNA repair. Herein, we summarise the current knowledge concerning improved genome integrity in non-transformed stem cells and CSCs, discuss therapeutic opportunities within the DDR for re-sensitising CSCs to genotoxic stressors, and consider the challenges posed regarding unbiased identification of novel DDR-directed strategies in CSCs. A better understanding of the DDR mediating chemo/radioresistance mechanisms in CSCs could lead to novel therapeutic approaches, thereby enhancing treatment efficacy in cancer patients.

Schlagwörter

Stichwörter der Autor:innen

DNA damage responseDNA repairbreast cancer stem cellscancer stem cellschemoresistancehomologous recombinationnon-homologous end-joiningradioresistancesplicingtumour-initiating cells

Autor:innen und Institutionen

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • School of Cancer Sciences, University of Southampton, Southampton SO16 6YD, UK.

ORCID-Profile: Clare C Davies

Förderung

  • Cancer Research UK
  • University of Birmingham PhD studentship

Zitieren

APA

Gillespie, M. S., Ward, C. M., & Davies, C. C. (2023). DNA Repair and Therapeutic Strategies in Cancer Stem Cells. Cancers, 15(6), 1897. https://doi.org/10.3390/cancers15061897

Vancouver

Gillespie MS, Ward CM, Davies CC. DNA Repair and Therapeutic Strategies in Cancer Stem Cells. Cancers. 2023;15(6):1897. doi:10.3390/cancers15061897

BibTeX
@article{Gillespie2023,
  author = {Gillespie, Matthew S and Ward, Ciara M and Davies, Clare C},
  title = {DNA Repair and Therapeutic Strategies in Cancer Stem Cells},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1897},
  doi = {10.3390/cancers15061897}
}
Kostenlos starten →